NewsFeed Voices Science Insight Innovation
January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Brad Pick Highlights PPTA’s Insights on Plasma Therapies for Trauma, Surgery and Chronic Illnesses
pptaglobal.org
Sep 21, 2025, 05:41

Brad Pick Highlights PPTA’s Insights on Plasma Therapies for Trauma, Surgery and Chronic Illnesses

 

Brad Pick, Senior Director Global External Communications at Grifols, shared a post by Plasma Protein Therapeutics Association (PPTA) on LinkedIn: 

”What many don’t realize is that plasma therapeutics treat more than rare and chronic diseases. They have a vital role in treating everyday   medical situations such as trauma and major surgery. That’s something all of us can relate to.”

Quoting Plasma Protein Therapeutics Association (PPTA)‘s post:

”Using specialized techniques, pooled plasma is separated and purified, and each protein undergoes advanced processes for therapeutic   safety.

These manufacturing steps lead to plasma-derived medicines, such as albumin, immunoglobulins, coagulation factors, C1 esterase inhibitors,  and Alpha-1 proteinase inhibitors.

These plasma-derived medicines are used to treat a range of conditions, from immunodeficiencies to blood clotting disorders, highlighting   the critical role plasma proteins play in a variety of conditions – more of which are being discovered every day.

Learn more about the journey of plasma-derived medicines on our YouTube channel.”

See the Plasma Protein Therapeutics Association (PPTA) post here.

PPTA

Stay updated with Hemostasis Today.

Brad Pick Grifols Health Hematology Hemostasis Hemostasis Today Medicine Plasma Donation Plasma Protein Therapeutics Association Plasma-derived medicines PPTA thrombosis Transfusion Medicine
NewsFeed